newdrugapprovals.org
Catalyst’s Firdapse Gets FDA ‘Breakthrough’ Designation
amifampridine used as phosphate salt Catalyst Pharmaceutical Partners Receives Breakthrough Therapy Designation From FDA for Firdapse(TM) for the Treatment of LEMS CORAL GABLES, Fla., Aug. 27, 2013…